Dominant (mono-allelic) mutations in multiple ARSs genes (GARS, YARS, AARS, and HARS) have been associated with the progressive axonal neuropathy Charcot Marie Tooth type 2 Disease33–38, presumably acting in a dominant-negative capacity. This evidence concerns the gene YARS1 and Charcot-Marie-Tooth disease type 2.